(lp0
S'Drilling Down Into Merrimack Pharmaceuticals, Inc.  StockNewsJournal - 14 hours ago Merrimack Pharmaceuticals, Inc.  is an interesting player in the Healthcare space, with a focus on Biotechnology.Tudor Investment Corp Et Al Takes Position in Merrimack Pharmaceuticals Inc  - The Cerbat GemMerrimack Pharmaceuticals, Inc.  shows monthly volitility of 4.70% - The Newburgh Press'
p1
aS'Stock Returns: PDL BioPharma Inc  is Beating Merrimack ... CML News - Mar 27, 2017 This is a snapshot to compare the stock returns for Merrimack Pharmaceuticals Inc  versus PDL BioPharma Inc  .'
p2
aS'Company Update : Merrimack Pharmaceuticals Inc Announces 4Q and ... Smarter Analyst - Mar 1, 2017 Merrimack Pharmaceuticals, Inc. engages in discovering, developing and preparing to commercialize innovative medicines consisting of novel therapeutics paired with diagnostics for the treatment of cancer.Merrimack Pharmaceuticals Inc.: Merrimack Reports Fourth Quarter and Full-Year ... - The Wall Street TranscriptFeatured Stock to See: Merrimack Pharmaceuticals, Inc.  - HugoPress'
p3
aS'Stock Alert and Holding Pattern: Merrimack Pharmaceuticals Inc Stock ... CML News - 20 hours ago Before we cover the full analysis we make a quick alert here that Merrimack Pharmaceuticals Inc  has seen its stock price move at an amplified level.'
p4
aS'Earnings Reaction History: Merrimack Pharmaceuticals Inc, 36.4% Follow-Through ... Nasdaq - Mar 1, 2017 Merrimack Pharmaceuticals Inc  is due to issue its quarterly earnings report in the upcoming extended-hours session.'
p5
aS'Buy or Sell? Average Brokerage Ratings on Merrimack Pharmaceuticals, Inc ... StockNewsJournal - Mar 22, 2017 ROI deals with the invested cash in the company and the return the investor realize on that money based on the net profit of the business.'
p6
aS'Investor Chatter: Looking at Shares of Merrimack Pharmaceuticals, Inc. (NASDAQ ... The Standard - 15 hours ago Merrimack Pharmaceuticals, Inc.  has an EV  of 614867. Enterprise Value measures the complete value of a specific company.'
p7
aS"Merrimack Pharmaceuticals, Inc.'s  stock price is Worth at $3.06 while ... Hot Stocks Point - 20 hours ago USA based company, Merrimack Pharmaceuticals, Inc. 's latest closing price distance was at -36.10% from the average-price of 200 days while it maintained a distance from the 50 Day Moving Average at -1.96% and -1.80% compared with the 20 Day&nbsp;..."
p8
aS'Merrimack Pharmaceuticals, Inc. : Getting Technical With The Stock USA Commerce Daily - 13 hours ago With all other things going on, Merrimack Pharmaceuticals, Inc.  has been on a free fall - declining -27.14 percent in just three months.'
p9
aS'The Case for and Against Merrimack Pharmaceuticals, Inc.  StockNewsJournal - Mar 23, 2017 Merrimack Pharmaceuticals, Inc.  is an interesting player in the Healthcare space, with a focus on Biotechnology.'
p10
a.